Nonalcoholic fatty liver disease (NAFLD) is characterized by high levels of nonesterified fatty
acids (NEFA), inflammation, and hepatic steatosis. Inflammation plays a crucial role in the …

Aim: To investigate whether resveratrol (RSV) can improve non-alcoholic fatty liver disease
(NAFLD) and to find the possible mechanism. Methods: Rats fed a high-fat diet were treated …

Introduction: Nonalcoholic fatty liver disease (NAFLD) is a chronic disease characterized by
fat deposits in liver cells, which can lead to hepatitis and fibrosis. This study attempted to …

In this study, we aimed to investigate the therapeutic effects and involved mechanisms of
resveratrol on an established non-alcoholic fatty liver disease (NAFLD) murine model. Wild …

Objective Resveratrol (RSV) is the most studied natural compound that activates sirtuins,
which produce beneficial metabolic effects on lipid and glucose metabolism. The aim of the …

Our previous studies suggested that salidroside could alleviate hepatic steatosis in type 2
diabetic C57BLKS/Leprdb (db/db) mice. The aim of the present study was to evaluate the …

Non-alcoholic fatty liver disease (NAFLD) is associated with low-grade chronic inflammation
and intestinal dysbiosis. In this study, we investigated the potential benefits of sinapine, a …

Nonalcoholic steatohepatitis (NASH) is considered as a common liver disease. SIRT1, a
pivotal sensor, controls activation of metabolic, inflammatory and apoptotic pathways …

Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease.
Dietary supplementation has become a promising strategy for managing NAFLD …

Alcoholic liver disease (ALD) is caused by chronic excessive alcohol consumption, which
leads to inflammation, oxidative stress, lipid accumulation, liver fibrosis/cirrhosis, and even …